VARICELLA ZOSTER VIRUS (VZV) VACCINE
Aspects of the disclosure relate to nucleic acid vaccines. The vaccines include at least one RNA polynucleotides having an open reading frame encoding at least one varicella zoster virus (VZV) antigen. Methods for preparing and using such vaccines are also described.
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English |
Published |
05.03.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Aspects of the disclosure relate to nucleic acid vaccines. The vaccines include at least one RNA polynucleotides having an open reading frame encoding at least one varicella zoster virus (VZV) antigen. Methods for preparing and using such vaccines are also described. |
---|---|
Bibliography: | Application Number: US201816494162 |